Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155814 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects
A Phase 1 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 196
- Enrollment target
NCT04155814 is a Phase 1 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 196 participants.
The verdict
NCT04155814, a Phase 1 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 196 participants
- Enrollment target
Study Summary
This study evaluates the bioequivalence, pharmacokinetic (PK) profile, and safety and tolerability of Iron Sucrose (Test Product) relative to that of Venofer® in healthy subjects.
Interventions
- DRUG Iron Sucrose Injection
- DRUG Venofer Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2019-12-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155814
The ClinicalTrials.gov registry entry for NCT04155814 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iron Sucrose Injection is the first listed.
NCT04155814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04155814 about?
NCT04155814 is a clinical study titled "Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects". This study evaluates the bioequivalence, pharmacokinetic (PK) profile, and safety and tolerability of Iron Sucrose (Test Product) relative to that of Venofer® in healthy subjects.
What is the current status of trial NCT04155814?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 196 participants. The study started on 2019-09-19. Estimated completion is 2019-12-18.
What interventions are being tested in trial NCT04155814?
The interventions under investigation include: Iron Sucrose Injection (DRUG), Venofer Injection (DRUG).
Who is sponsoring clinical trial NCT04155814?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.